Nanocapsules could reduce existing treatment’s side effects
Blood clot-busting nanocapsules could reduce existing treatment’s side effects: Imperial researchers have designed drug delivery nanocapsules that could reduce the…
Heart & Lung
Funding boost for vulnerable Australian cardiac patients
Funding boost gives hope to vulnerable Australian cardiac patients: A Curtin University research team has been awarded almost $1.5million in…
Results of the COLCORONA study
Results of the COLCORONA study published in The Lancet Respiratory Medicine - Colchicine could be considered as a treatment for…
Victory for thousands of terminally ill patients
Antifibrotic drugs offer hope to thousands of patients who are living with a condition that has a worse outcome than…
WHO: Long working hours increasing deaths
Long working hours increasing deaths from heart disease and stroke: WHO, ILO: Long working hours led to 745 000 deaths…
Mouse studies find sugar-free energy drinks just as harmful
Mouse studies find sugar-free energy drinks just as harmful: Two Curtin research studies have found the excessive consumption of energy…
Future of lung disease care ‘at risk’
Future of lung disease care ‘at risk’ due to workforce shortages and backlog from COVID-19: Staffing shortages are impacting diagnosis, treatment,…
Novel non-coding RNAs regulating blood vessel formation
Researchers at the University of Eastern Finland have discovered previously unknown non-coding RNAs (ncRNAs) involved in regulating the gene expression…
COVID-19 impact on blood vessels and heart health
COVID-19 may have long-term impact on blood vessels and heart health: New research published in Experimental Physiology highlight the possible long term…
NICE guidelines will delay AF diagnosis
NICE guidelines will delay AF diagnosis: AF Association welcomes the new National Institute for Health and Care Excellence (NICE) guideline…